The association between inhaled corticosteroid and the risks of SARS-COV-2 infection: A systematic review and meta-analysis
Description
CONCLUSIONS: The use of ICS, either monotherapy or in combination with bronchodilators, does not have impact on the risk of SARS-COV-2 infection.
